OT8 Bob Duggan is the Golden Thetan who has donated over $500 million to the Church of Scientology.
However, Bob is now in danger as the stock price of his Pharma company Summit Therapeutics (trading symbol SMMT) statcrashed today to a new 52-week low of $13.81.
SMMT revivified at end of the day to an anemic $14.11.
In order to save Golden Thetan Bob Duggan and his company Summit Therapeutics, COB RTC Mr. David Miscavige today issued a new “handling suppressive molecules” policy — which is based on the Lost Tech of LRH found by COB.
KSMMT SERIES 1 — KEEPING SUMMIT THERAPEUTICS WORKING
Getting the correct molecule audited consists of:
One: Having the correct molecule. Ivonescimab, prophesied by Our Founder in 1962 and confirmed by acrostic. All other molecules are mere arbitraries.
Two: Knowing the molecule. An auditor who cannot locate a benzene ring’s false purpose has no business near the periodic table.
Three: Knowing it is correct. The molecule is correct because the share price is theta and the share price is theta because the molecule is correct. This is not circular; it is a closed valence shell.
Four: Teaching correctly the correct molecule. Every public shall be drilled on the E-Meter until oxygen reads clean and hydrogen stops dramatizing.
Five: Applying the molecule. The molecule is administered to the patient and, where the patient resists, to the patient’s case. Out-ethics is the only true illness; the tumor is merely a withhold with mass.
Six: Seeing that the molecule is correctly applied. Ethics Officer Bud Hurlbutt of the Molecular Ethics Division shall verify that no covalent bond has gone undeclared and that all lone pairs are on their ethics conditions.
Seven: Hammering out of existence incorrect molecules. Any compound that fails to read on the cans, or that postulates its own purpose without command intention, is to be routed to the SP Hole of the test tube.
Eight: Knocking out incorrect applications. The administering of placebos, peer review, or FDA Phase III data is hereby declared a high crime against the tech.
Nine: Closing the door on any possibility of incorrect molecules. There shall be one molecule. The door is closed. The door was always closed. Our Founder closed it in 1962, before the door existed.
Ten: Closing the door on incorrect application. Anyone observing that ivonescimab is a perfectly ordinary bispecific antibody, and not the pharmacological fulfillment of LRH prophecy, will route to Qual, then to Ethics, then to the curb.
Categories: OT8 Bob Duggan & Summit Therapeutics

